A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model

被引：0
|
作者：
Lorenzo Argante
Victoria Abbing-Karahagopian
Kumaran Vadivelu
Rino Rappuoli
Duccio Medini
机构：
[1] GSK,
[2] GSK,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
Invasive meningococcal disease; IMD; MenB; 4CMenB; Bexsero; Effectiveness; VE; Incidence model; Screening method; Epidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Challenges in synthesis of real-world vaccine effects on meningococcal serogroup B disease for 4CMenB vaccine post-licensure effectiveness studies: A systematic review
    Cinconze, Elisa
    Rosillon, Dominique
    Rappuoli, Rino
    Vadivelu, Kumaran
    Bekkat-Berkani, Rafik
    Abbing-Karahagopian, Victoria
    VACCINE, 2023, 41 (30) : 4347 - 4358
  • [32] Multicomponent Meningococcal Serogroup B Vaccine (4CMenB; Bexsero®): A Review of its Use in Primary and Booster Vaccination
    Natalie J. Carter
    BioDrugs, 2013, 27 : 263 - 274
  • [33] Multicomponent Meningococcal Serogroup B Vaccine (4CMenB; Bexsero®): A Review of its Use in Primary and Booster Vaccination
    Carter, Natalie J.
    BIODRUGS, 2013, 27 (03) : 263 - 274
  • [34] Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Neisseria meningitidis Strains and Their Predicted Coverage by the 4CMenB Vaccine
    Tsang, Raymond S. W.
    Law, Dennis K. S.
    De Paola, Rosita
    Giuliani, Maria
    Stella, Maria
    Zhou, Jianwei
    Deng, Saul
    Boccadifuoco, Giuseppe
    Giuliani, Marzia Monica
    Serino, Laura
    MSPHERE, 2020, 5 (02)
  • [35] The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae
    Leduc, Isabelle
    Connolly, Kristie L.
    Begum, Afrin
    Underwood, Knashka
    Darnell, Stephen
    Shafer, William M.
    Balthazar, Jacqueline T.
    Macintyre, Andrew N.
    Sempowski, Gregory D.
    Duncan, Joseph A.
    Little, Marguerite B.
    Rahman, Nazia
    Garges, Eric C.
    Jerse, Ann E.
    PLOS PATHOGENS, 2020, 16 (12)
  • [36] Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020
    Muzzi, Alessandro
    Lu, Min-Chi
    Mori, Elena
    Biolchi, Alessia
    Fu, Tiffany
    Serino, Laura
    MSPHERE, 2024, 9 (06)
  • [37] Correction to: Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
    Stefan Scholz
    Magdalena Schwarz
    Ekkehard Beck
    Kinga Meszaros
    Melanie Schneider
    Bernhard Ultsch
    Wolfgang Greiner
    Infectious Diseases and Therapy, 2022, 11 : 1311 - 1311
  • [38] Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland
    Mulhall, Robert M.
    Bennett, Desiree
    Cunney, Robert
    Borrow, Ray
    Lucidarme, Jay
    Findlow, Jamie
    Jolley, Keith A.
    Bray, James
    Maiden, Martin C. J.
    Moschioni, Monica
    Serino, Laura
    Stella, Maria
    Medini, Duccio
    MSPHERE, 2018, 3 (04):
  • [39] Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices
    Sohn, Woo-Yun
    Tahrat, Halima
    Novy, Patricia
    Bekkat-Berkani, Rafik
    EXPERT REVIEW OF VACCINES, 2022, 21 (03) : 325 - 335
  • [40] 4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents
    Biolchi, Alessia
    Tomei, Sara
    Brunelli, Brunella
    Giuliani, Maria
    Bambini, Stefania
    Borrow, Ray
    Claus, Heike
    Gorla, Maria Cecilia O.
    Hong, Eva
    Lemos, Ana Paula S.
    Lucidarme, Jay
    Taha, Muhamed-Kheir
    Vogel, Ulrich
    Budroni, Sonia
    Giuliani, Marzia M.
    Rappuoli, Rino
    Boucher, Philip
    Pizza, Mariagrazia
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 307 - 316
12345